Applied Therapeutics Inc: Patents

View up-to-date information on Applied Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
EP4041219A1	Application	ALDOSE-REDUKTASE-INHIBITOREN ZUR BEHANDLUNG VON PHOSPHOMANNOMUTASE-2-MANGEL	A61K31/5025; A61P25/00	August 17, 2022
US20220226323A1	Application	ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCY	A61K31/5025	July 21, 2022
IL291946D0	Application	Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency	A61K31/5025; A61P25/00	June 01, 2022
IL291946A	Application	Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency	A61K31/5025; A61P25/00	June 01, 2022
AU2020363699A1	Application	Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency	A61K31/5025; A61P25/00	May 26, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer